Cargando…
The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When “non-urgent” does not mean “deferrable”
Autores principales: | Pugliese, Daniela, Papi, Claudio, Privitera, Giuseppe, Aratari, Annalisa, Festa, Stefano, Armuzzi, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301120/ https://www.ncbi.nlm.nih.gov/pubmed/32601025 http://dx.doi.org/10.1016/j.dld.2020.05.053 |
Ejemplares similares
-
Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection
por: Festa, Stefano, et al.
Publicado: (2022) -
No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience
por: De Biasio, Fabiola, et al.
Publicado: (2021) -
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns
por: Festa, Stefano, et al.
Publicado: (2020) -
Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study
por: Pugliese, Daniela, et al.
Publicado: (2018) -
Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative review
por: Ratajczak, Alicja Ewa, et al.
Publicado: (2023)